In humans, there are sets of genes that encode enzymes that decrease or increase the risks derived from exposure to pesticides. These include DNA repair genes (XRCC1, OGG1 and XRCC4); pesticide metabolizers (GSTP1 and PON1), and genes that act against oxidative stress (SOD2 and NQO1).

The aim of this literature review is to provide information about the genes involved in the defence systems against exposure to pesticides, as well as their polymorphisms, functions, and general characteristics of the encoded enzymes.

Material and Methods:
Information was obtained from scientific articles published between 2015–2020 in the PubMed database (

Genes related to the defence processes against pesticides present single-nucleotide polymorphisms (SNPs) with allelic variants that affect the expressions or structures of the encoded enzymes, negatively altering their activities. If we knew the genetic profile that includes polymorphisms of DNA-repairing genes, metabolizing genes, and genes against oxidative stress in subjects exposed to pesticides, we would also know about their susceptibility to poisoning caused by these chemicals.

The genes could be used to propose a genetic profile in farmers exposed to various pesticides, including 10 gene polymorphisms involved in susceptibility to various pathologies related to DNA repair, xenobiotic metabolism, and oxidative stress. It could also be useful as a preventive measure to identify susceptibility to pesticide poisoning.

Arévalo-Jaramillo P, Idrobo A, Salcedo L, Cabrera A, Vintimilla A, Carrión M, Bailon-Moscoso N. Biochemical and genotoxic effects in women exposed to pesticides in Southern Ecuador. Environ Sci Pollut Res. 2019; 26(24): 24911–24921.
Markus V, Terali K, Dalmizrak O, Ozer N. Assessment of the inhibitory activity of the pyrethroid pesticide deltamethrin against human placental glutathione transferase P1–1: A combined kinetic and docking study. Environ Toxicol Pharmacol. 2018; 61: 18–23.
Ahmadi N, Mandegary A, Jamshidzadeh A, Mohammadi-Sardoo M, Mohammadi-Sardo M, Salari E, Pourgholi L. Hematological abnormality, oxidative stress, and genotoxicity induction in the greenhouse pesticide sprayers; investigating the role of NQO1 gene polymorphism. Toxics. 2018; 6(1): 1–15. 10.3390/toxics6010013.
Garcia-Rodriguez A, de la Casa M, Serrano M, Gosálvez J, Roy Barcelona R. Impact of polymorphism in DNA repair genes OGG1 and XRCC1 on seminal parameters and human male infertility. Andrologia. 2018; 50(10): 1–7.
Zhang, Jiang D, Wang C, Garzotto M, Kopp R, et al. Polymorphisms in oxidative stress pathway genes and prostate cancer risk. Cancer Causes and Control. 2019; 30(12): 1365–1375.
Sharma N, Singhvi R. Effects of Chemical Fertilizers and Pesticides on Human Health and Environment: A Review. International Journal of Agriculture, Environment and Biotechnology. 2017; 10(6): 675–679. doi: 10.5958/2230-732X.2017.00083.3.
Zhang C, Hu R, Huang J, Huang X, Shi G, et al. Health effect of agricultural pesticide use in China: implications for the development of GM crops. Scientific Reports. 2016; 6(34918): 1–8.
de Adad LMM, De Andrade HHR, Kvitko K, Lehmann M, de Cavalcante AACM, Dihl RR. Occupational exposure of workers to pesticides: Toxicogenetics and susceptibility gene polymorphisms. Genet Mol Biol. 2015; 38(3): 308–315.
Godoy FR, Nunes HF, Alves AA, Carvalho WF, Franco FC, et al. Increased DNA damage is not associated to polymorphisms in OGGI DNA repair gene, CYP2E1 detoxification gene, and biochemical and hematological findings in soybeans farmers from Central Brazil. Environ Sci Poll Res. 2019; 26(26): 26553–26562.
Silva VF, Simon D, de Souza MR, da Rosa VH, Nicolau C, et al. Base excision repair (OGG1 and XRCC1) and metabolism (PON1) gene polymorphisms act on modulation of DNA damage and immune parameters in tobacco farmers. Mutat Res Genet Toxicol Environ Mutagen. 2018; 836 9–18.
de Oliveira AFB, de Souza MR, Benedetti D, Scotti AS, Piazza LS, et al. Investigation of pesticide exposure by genotoxicological, biochemical, genetic polymorphic and in silico analysis. Ecotoxicol Environ Saf. 2019; 179: 135–142.
Mahmoud AA, Hassan MH, Ghweil AA, Abdelrahman A, Mohammad AN, Ameen HH. Urinary 8-hydroxydeoxyguanosine in relation to XRCC1 rs25487 G/A (Arg399Gln) and OGG1 rs1052133 C/G (Ser326Cys) DNA repair genes polymorphisms in patients with chronic hepatitis C and related hepatocellular carcinoma. Cancer Manag Res. 2019; 11: 5343–5351.
Saad-Hussein A, Noshy M, Taha M, El-Shorbagy H, Shahy E, Abdel-Shafy EA. GSTP1 and XRCC1 polymorphisms and DNA damage in agricultural workers exposed to pesticides. Mutat Res Genet Toxicol Environ Mutagen. 2017; 819: 20–25.
Kaur J, Sambyal V, Guleria K, Singh NR, Uppal MS, Manjari M, Sudan M. Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk. Clin Exp Gastroenterol. 2020; 13: 73–86.
de Melo e Silva D, Alves AA, Nunes HF, Ramos JSA, Franco FC, Soares TN. Evaluating the OGG1 rs1052133 and rs293795 polymorphisms in a sample of rural workers from Central Brazil population: a comparative approach with the 1000 Genomes Project. Environ Sci Pollut Res. 2018; 25(25) 25612–25617.
Garcia JA, Kalacas NA, Ortin TS, Ramos MC, Albano PM. XRCC4 c.1394G > T single nucleotide polymorphisms and breast cancer risk among filipinos. Asian Pac J Cancer Prev. 2019; 20(4): 1097–1101.
Gupta MK, Kushwah AS, Singh R, Banerjee M. Genotypic analysis of XRCC4 and susceptibility to cervical cancer. Br J Biomed Sci. 2020; 77(1): 7–12
Singh PK, Mistry KN, Chiramana H, Rank DN, Joshi CG. Exploring the deleterious SNPs in XRCC4 gene using computational approach and studying their association with breast cancer in the population of West India. Gene. 2018; 655: 13–19.
Floris M, Sanna D, Castiglia P, Putzu C, Sanna V, et al. MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia. BMC Cancer. 2020; 20(234): 1–15.
Fujihara J, Yasuda T, Iwata H, Tanabe S, Takeshita H. Association of XRCC1 polymorphisms with arsenic methylation. Arch Toxikol. 2016; 90(4): 1009–1012. doi: 10.1007/s00204-015-1490-0.
Sobiahe A, Hijazi E, Al-Ameer HJ, Almasri Y, Jarrar Y, et al. Arg399Gln XRCC1 Polymorphism and Risk of Squamous Cell Carcinoma of the Head and Neck in Jordanian Patients. Asian Pac J Cancer Prev. 2020; 21(3): 663–665.
Xu C, Xu J, Ji G, Liu Q, Shao W, et al. Deficiency of X-ray repair cross-complementing group 1 in primordial germ cells contributes to male infertility. FASEB J. 2019; 33(6): 7427–7436.
Hassan FM. OGG1 rs1052133 polymorphism and genetic susceptibility to chronic myelogenous leukaemia. Asian Pac J Cancer Prev. 2019; 20(3): 925–928.
Dinçer Y, Akkaya Ç, Mutlu T, Yavuzer S, Erkol G, Bozluolcay M, Guven M. DNA repair gene OGG1 polymorphism and its relation with oxidative DNA damage in patients with Alzheimer’s disease. Neurosci Lett. 2019; 709: 134362.
Das S, Nath S, Bhowmik A, Ghosh SK, Choudhury Y. Association between OGG1 Ser326Cys polymorphism and risk of upper aero-digestive tract and gastrointestinal cancers: a meta-analysis. SpringerPlus. 2016; 5: 1–11.
Sanjari MA, Nazarzadeh M, Noroozi R, Darvish H, Jarrahi AM. XRCC1 and OGG1 gene polymorphisms and breast cancer: A systematic review of literature. Int J Cancer Man. 2016; 9(1): e3467.
Pehlivan S, Balci SO, Aydeniz A, Pehlivan M, Sever T, Gursoy S. Might there be a link between intron 3 VNTR polymorphism in the XRCC4 DNA. Genet Test Mol Biomarkers. 2015; 19(1): 48–51.
Saito S, Kurosawa A, Adachi N. Mutations in XRCC4 cause primordial dwarfism without causing immunodeficiency. J Hum Genet. 2016; 61: 679–685.
Silva VF, da Silva FR, Alves JS, da Silva GF, Picinini J, et al. Role of PON1, SOD2, OGG1, XRCC1, and XRCC4 polymorphisms on modulation of DNA damage in workers occupationally exposed to pesticides. Ecotoxicol Environ. 2018; 15(159): 164–171.
Wen Y, Dai G, Wang L, Fu K, Zuo S. Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells. Biosci Rep. 2019; 39(3): 1–30.
Alleva R, Manzella N, Gaetani S, Bacchetti T, Bracci M, et al. Mechanism underlying the effect of long-term exposure to low dose of pesticides on DNA integrity. Environ Toxicol. 2018; 33(4): 476–487.
Kudhair BK, Alabid NN, Taheri-Kafrani A, Lafta IJ. Correlation of GSTP1 gene variants of male Iraqi waterpipe (Hookah) tobacco smokersand the risk of lung cancer. Mol Biol Rep. 2020; 47: 2677–2684.
Mandal RK, Mittal RD. Glutathione S-Transferase P1 313 (A > G) Ile105Val Polymorphism Contributes to Cancer Susceptibility in Indian Population: A Meta-analysis of 39 Case–Control Studies. Indian J Clin Biochem. 2020; 35(1): 8–19.
Dardiotis E, Aloizou AM, Siokas V, Tsouris Z, Rikos D, et al. Paraoxonase-1 genetic polymorphisms in organophosphate metabolism. Toxicol. 2019; 411: 24–31.
Xotlanihua-Gervacio MC, Herrera-Moreno JF, Medina-Díaz IM, Bernal-Hernández YY, Rothenberg SJ, Barrón-Vivanco BS, Rojas-García AE. Relationship between internal and external factors and the activity of PON1. Environ Sci Poll Res. 2019; 26(24): 24946–24957.
Luo Y, Tan Y, Wang X. Influence of polymorphisms in VEGF, TNF-?, and GSTP1 genes on retinopathy of prematurity risk: a Meta-analysis. J of Matern Fetal Neonatal Med. 2020; 86: 1–10.
Drozdz-Afelt JM, Koim-Puchowska B, Klosowski G and Kaminski P. Polymorphism of glutathione S-transferase in the population of Polish patients with carcinoma of the prostate. Environ Sci Poll Res. 2020; 27: 19375–19382.
Idris HM, Elderdery AY, Khalil HB, Mills J. Genetic Polymorphism of GSTP1, GSTM1 and GSTT1 Genes and Susceptibility to Chronic Myeloid Leukaemia. Asian Pac J Cancer Prev. 2020; 21(2): 499–503.
Tian M, Zhao B, Martin FL, Morais CLM, Liu L, et al. Gene-environment interactions between GSTs polymorphisms and targeted epigenetic alterations in hepatocellular carcinoma following organochlorine pesticides (OCPs) exposure. Environ Int. 2020; 134: 105313.
Lee YH, Kim JH, Seo YH, Choi SJ, Ji JD, Song GG. Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis. Neurol Sci. 2015; 36(1): 11–20.
Mota A, Hemati-Dinarvand M, Akbar TA, Reza NH, Ahmadi R, et al. Association of Paraoxonse1 (PON1) Genotypes with the Activity of PON1 in Patients with Parkinson’s Disease. Acta Neurol Taiwan. 2019; 28(3): 66–74.
Medina-Díaz IM, Ponce-Ruiz N, Ramírez-Chávez B, Rojas-García AE, Barrón-Vivanco BS, Elizondo G, Bernal-Hernández YY. Downregulation of human paraoxonase 1 (PON1) by organophosphate pesticides in HepG2 cells. Environ Toxicol. 2017; 32(2): 490–500.
Torres-Sánchez L, Gamboa R, Bassol-Mayagoitia S, Huesca-Gómez C, Nava MP, et al. Para-occupational exposure to pesticides, PON1 polymorphisms and hypothyroxinemia during the first half of pregnancy in women living in a Mexican floricultural area. Environ Health. 2019; 18(33): 1–10.
Sunay SZ, Kayaalti Z, Bayrak T, Söylemezoglu T. Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate. Toxicol Ind Health. 2015; 31(12): 1061–1068.
Amr S, Dawson R, Saleh DA, Magder LS, George DM, et al. Pesticides, Gene Polymorphisms, and Bladder Cancer among Egyptian Agricultural Workers. Arch Environ Occup Health. 2015; 70(1): 19–26.
Pourvali K, Abbasi M, Mottaghi A. Role of superoxide dismutase 2 gene Ala16Val polymorphism and total antioxidant capacity in diabetes and its complications. Avicenna J Med Biotechnol. 2016; 8: 48–56.
Ait TAEK, Becquemont L, El-Asmar K, Mahmoudi K, Colle R, et al. SOD2 genetic polymorphism (rs4880) has no impact on 6-month response to antidepressant treatment and inflammatory biomarkers in depressed patients. Basic Clin Pharmacol Toxicol. 2020; 126(3): 289–295.
Kim YS, Vallur PG, Phaëton R, Mythreye K, Hempel N. Insights into the dichotomous regulation of SOD2 in cancer. Antioxidants. 2017; 6(86): 1–25.
Moumad K, Khaali W, Benider A, Ben AW, Hamdi-Cherif M, et al. Joint effect of smoking and NQO1 C609T polymorphism on undifferentiated nasopharyngeal carcinoma risk in a North African population. Mol Genet Genomic Med. 2018; 6(6): 933–940.
Dragicevic B, Suvakov S, Jerotic D, Reljic Z, Djukanovic L, et al. Association of SOD2 (Rs4880) and GPX1 (rs1050450) gene polymorphisms with risk of Balkan endemic nephropathy and its related tumors. Medicina (Lithuania). 2019; 55(8): 1–10.
Taş A, Silig Y, Pinarbaşi H, Gürelik M. Role of SOD2 ala16Val polymorphism in primary brain tumors. Biomed Rep. 2019; 10(3): 189–194.
Berto MD, Bica CG, de Sá GP, Barbisan F, Azzolin VF, et al. The effect of superoxide anion and hydrogen peroxide imbalance on prostate cancer: an integrative in vivo and in vitro analysis. Medical Oncol. 2015; 32(11): 251.
Liu C, Fang J, Liu W. Superoxide dismutase coding of gene poly-morphisms associated with susceptibility to Parkinson’s disease. J Integ Neurosci. 2019; 18(3): 299–303.
Silva CB, Mota CL, Almeida YR, Emídio V, Fonseca ASA, Mitri S, Moreira JC. Environmental exposure to benzene: evaluation of urinary S-PMA and polymorphism (CYP2E1–1293G>C and NQO1 609C>T) in Campos Elíseos residents, Duque de Caxias, Rio de Janeiro State, Brazil. Cad Saude Publica. 2019; 35(7): e00198618.
Zhao L, Liu J, Tan P, Zhang W, Gao Q, et al. Genetic association of the NQO1 rs1800566 (609C>T) variant with risk of preeclampsia in the Chinese Han population. Pregnancy Hypertens. 2017; 10: 42–45.
Yu L, Hu Y, Ding Y. Association of maternal xenobiotic-metabolizing gene polymorphisms with risk of fetal growth restriction. Per Med. 2019; 16(4): 269–276.
Chung JE, Chang BC, Lee KE, Kim JH, Gwak HS. Effects of NAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves. Eur J Clin Pharmacol. 2015; 71(10): 1229–1236.